Showing results (341-350 of 358) with videos related to
Sort By:
Pageof 36
Nature Communications|July 21, 2022
Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degenerationRaquel Gomez-Sintes, Qisheng Xin, Juan Ignacio Jimenez-Loygorri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patientsAndrew P Garner, Joseph M Gozgit, Rana Anjum, et al.Journal of Experimental & Clinical Cancer Research : CR|December 17, 2013
On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium saltsSara Iachettini, Malcolm Fg Stevens, Mark Frigerio, et al.ACS Omega|January 26, 2026
Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment ApproachPaola Di Lello, Marta M Wells, Ben Davis, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2013
Association between celiac disease and iron deficiency in Caucasians, but not non-CaucasiansJoseph A Murray, Stela McLachlan, Paul C Adams, et al.Plos One|April 13, 2011
Genome-wide association study identifies genetic loci associated with iron deficiencyChristine E McLaren, Chad P Garner, Clare C Constantine, et al.Lancet (London, England)|April 30, 2002
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trialM Adjuik, P Agnamey, A Babiker, et al.Nature Communications|July 7, 2022
Modulating mitofusins to control mitochondrial function and signalingEmmanouil Zacharioudakis, Bogos Agianian, Vasantha Kumar Mv, et al.Clinical and Translational Medicine|May 1, 2021
Full closed loop open-source algorithm performance comparison in pigs with diabetesRayhan A Lal, Caitlin L Maikawa, Dana Lewis, et al.Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.Pageof 36